Similar articles

• Cetuximab-induced acneiform eruption and the response to isotretinoin.

  Vezzoli P, Marzano AV, Onida F, Alessi E, Galassi B, Tomirotti M, Berti E. Vezzoli P, et al. Acta Derm Venereol. 2008;88(1):84-6. doi: 10.2340/00015555-0330. Acta Derm Venereol. 2008. PMID: 18176767 No abstract available.
• Topical therapy with nadifloxacin cream and prednicarbate cream improves acneiform eruptions caused by the EGFR-inhibitor cetuximab - A report of 29 patients.

  Katzer K, Tietze J, Klein E, Heinemann V, Ruzicka T, Wollenberg A. Katzer K, et al. Eur J Dermatol. 2010 Jan-Feb;20(1):82-4. doi: 10.1684/ejd.2010.0806. Epub 2009 Oct 2. Eur J Dermatol. 2010. PMID: 19797039 Clinical Trial.
• [Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid].

  Wollenberg A, Moosmann N, Kroth J, Heinemann V, Klein E. Wollenberg A, et al. Hautarzt. 2007 Jul;58(7):615-8. doi: 10.1007/s00105-006-1256-y. Hautarzt. 2007. PMID: 17146641 German.
• The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies.

  Segaert S, Tabernero J, Chosidow O, Dirschka T, Elsner J, Mancini L, Maughan T, Morere JF, Santoro A, Sobrero A, Van Cutsem E, Layton A. Segaert S, et al. J Dtsch Dermatol Ges. 2005 Aug;3(8):599-606. doi: 10.1111/j.1610-0387.2005.05058.x. J Dtsch Dermatol Ges. 2005. PMID: 16033478 Review.
• Cetuximab-associated infusion reactions: pathology and management.

  Patel DD, Goldberg RM. Patel DD, et al. Oncology (Williston Park). 2006 Oct;20(11):1373-82; discussion 1382, 1392-4, 1397. Oncology (Williston Park). 2006. PMID: 17112000 Review.